Treace Medical Concepts, Inc. (TMCI) stock
TMCINasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/3031% below fair value
$4.44+0.02 (+0.45%)
Close on Nov 17, 2026Market cap $288.75MP/E –Yield –
Treace Medical Concepts price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Treace Medical Concepts's price to sales ratio was 1.6× on Nov 11, 2026, against 0.9× a year earlier. Over the last 5 years it ranged from 0.4× to 12.4×, with a median of 3.1×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 1.6× | +0.9 |
| 2025 | Dec 31, 2025 | 0.7× | −1.6 |
| 2024 | Dec 31, 2024 | 2.3× | −2.2 |
| 2023 | Dec 29, 2023 | 4.5× | −5.7 |
| 2022 | Dec 30, 2022 | 10.2× | +0.5 |
| 2021 | Dec 31, 2021 | 9.7× | – |
See a number that looks wrong?